Genome-wide genetic screening in the mammalian CNS
Genes linked to major neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and Huntington’s diseases, were first identified over 15 years ago, but neither a full molecular explanation for the cell loss seen in human patients nor a curative therapy has yet been achieved for any of these di...
Main Authors: | Wertz, Mary H., Heiman, Myriam |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences |
Format: | Book chapter |
Language: | English |
Published: |
Springer International Publishing
2020
|
Online Access: | https://hdl.handle.net/1721.1/124812 |
Similar Items
-
Genome-wide In Vivo CNS Screening Identifies Genes that Modify CNS Neuronal Survival and mHTT Toxicity
by: Wertz, Mary H, et al.
Published: (2021) -
Resolving CNS mRNA Heterogeneity: Examining mRNA Alternative Polyadenylation at a Cell-Type-Specific Level
by: Therrien, Martine, et al.
Published: (2018) -
Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells
by: Wu, Xuebing, et al.
Published: (2015) -
Synthetic lethal screening in the mammalian central nervous system identifies Gpx6 as a modulator of Huntington’s disease
by: Kulicke, Ruth, et al.
Published: (2015) -
Improved vectors and genome-wide libraries for CRISPR screening
by: Sanjana, Neville E, et al.
Published: (2017)